Chemotherapy of stomach cancer in an oncology office
Gusarov, I.P.
Voprosy Onkologii 25(11): 58-59
1979
ISSN/ISBN: 0507-3758 PMID: 516567 Document Number: 148708
Up to date of the total number of gastric cancer patients, who referred to the polyclinic, only 13% were found to be curable, 27%--may be treated without any guarantee of success, while 60% of patients were incurable. Such patients were administered 5-fluorouracil under outpatient conditions. Totally, 38 patients were treated, 13 of them are now alive, 25--died. Our observations indicated that the treatment of patients in an oncological cabinet proves to be quite feasible, and the use of chemotherapy largely improve and prolong the survival of patients with far-advanced cancer.
Document emailed within 1 workday
Related Documents
Leichman, L.; Steiger, Z.; Seydel, H.G.; Vaitkevicius, V.K. 1984: Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience Seminars in Oncology 11(2): 178-185Moertel, C.G.; Lavin, P.T. 1979: Phase II-IIi chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group Cancer Treatment Reports 63(11-12): 1863-1869
Ychou, M. 1995: Is neoadjuvant chemotherapy necessary in cancer of the stomach? Annales de Gastroenterologie et d'Hepatologie 31(2): 132-133
Lipatov, A.M.; Karam, M.; Borisov, V.I.; Shkarenkov, V.A.; Buracheskaia, N.V. 1977: Chemotherapy of cancer of the proximal region of the stomach Klinicheskaia Meditsina 55(2): 41-47
Niimoto, M.; Nakagami, K.; Hirono, M.; Oride, M.; Hattori, T. 1983: Evaluation of chemotherapy for resected stomach cancer: second-look operation Gan no Rinsho. Japan Journal of Cancer Clinics 29(10): 1274-1278
Li, Y.; Liang, J.; Liu, W.-b.; Xu, X.-q.; Zhao, Y.-r. 2004: Influence of chemotherapy on Th1/Th2 cytokine switching in stomach cancer patients Zhonghua Zhong Liu Za Zhi 26(12): 732-734
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Amatatsu, M.; Okumura, H.; Uchikado, Y.; Megumi, K.; Kita, Y.; Uenosono, Y.; Arigami, T.; Mori, S.; Ishigami, S.; Owaki, T.; Natsugoe, S. 2015: A Case of Concurrent Cancer of the Esophagus and Stomach with Severe Sepsis following Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(10): 1322-1324
Káposztás, Z.; Cseke, L.ás.ó; Kalmár, K.; Horváth, O.P.ét. 2002: Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response Magyar Sebeszet 55(5): 321-324
Ostroverkhov, G.E.; Alimov, A.T. 1975: Certain results of the use of regional intra-arterial chemotherapy in inoperable cancer of the stomach Klinicheskaia Khirurgiia 7: 22-26
Gao, C.-M.; Lu, J.-W.; Toshiro, T.; Wu, J.-Z.; Cao, H.-X.; Chen, H.-Q.; Feng, J.-F.; Kazuo, T. 2004: Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy Zhonghua Liu Xing Bing Xue Za Zhi 25(12): 1054-1058
Orlovskaia, L.A.; Tiutiunova, A.M.; Kulikova, M.L.; Vagner, V.P. 1980: Change in the nonspecific resistance indices in stomach cancer under the influence of preoperative chemotherapy Sovetskaia Meditsina 1980(4): 33-35
Hogan, C.M.; Miller, S. 1986: The Oncology Nursing Society's: Cancer Chemotherapy: Guidelines and Recommendations for Nursing Education and Practice Progress in Clinical and Biological Research 216: 359-360
Sugawara, A.; Munakata, K.; Ishida, T.; Sato, S.; Yoshikawa, M.; Watanabe, K.; Saito, J.; Ohtsuka, Y.; Munakata, M. 2006: A case of advanced double cancer of the lung and stomach responding to combination chemotherapy of cisplatin and TS-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(7): 973-975
Kubota, E.; Kataoka, H.; Hayashi, K.; Kamiya, T.; Sasaki, M.; Ogasawara, N.; Yamada, T.; Wada, T.; Mori, Y.; Mizoshita, T.; Shimura, T.; Mizushima, T.; Okamoto, Y.; Ohara, H.; Joh, T. 2009: Advanced stomach and pancreas cancer successfully treated with combination chemotherapy with S-1/paclitaxel/lentinan Hepato-Gastroenterology 56(89): 106-110
Böttcher, K.; Siewert, J.R.; Roder, J.D.; Busch, R.; Hermanek, P.; Meyer, H.J. 1994: Risk of surgical therapy of stomach cancer in Germany. Results of the German 1992 Stomach Cancer Study. German Stomach Cancer Study Group ('92) Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(4): 298-306
Nishioka, B.; Ouchi, T.; Watanabe, S.; Umehara, M.; Yamane, E.; Yahata, K.; Muto, F.; Kojima, O.; Nomiyama, S.; Sakita, M.; Fujita, Y.; Majima, S. 1982: Follow-up study of preoperative oral administration of an antineoplastic agent as an adjuvant chemotherapy in stomach cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(8): 1427-1432
Kasai, Y.; Inokuchi, K.; Hattori, T.; Inoue, K.; Taguchi, T.; Kondo, T.; Akiyama, H.; Abe, O.; Ito, I.; Nakajima, T.; Muto, T.; Kikuchi, K.; Sugie, S.; Hayasaka, A. 1982: Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(8): 1449-1460
Yuen, A.R.; Fuks, J.Z.; Ettinger, D.S.; Chang, A.Y.; Ruckdeschel, J.C.; Phan, S.C.; Blum, R.H. 2000: Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586) Cancer Journal From Scientific American 6(1): 34-39
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35